MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)
A study to evaluate the cardiac and metabolic effects of MK0767 in patients with Type 2 Diabetes.
This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
Please refer to this study by its ClinicalTrials.gov identifier: NCT00543010
|Study Director:||Medical Monitor||Merck Sharp & Dohme Corp.|